Callan Family Office’s Walgreens Boots Alliance WBA Stock Holding History

Callan Family Office’s Portfolio WBA Stock Details WBA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-19,164	Closed	-$220K	–	953
2025 Q2	$220K	Buy	+19,164	New	+$213K	0.01%	870

Other funds holding WBA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

GCM

Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BCP

BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

PayPay Securities Tokyo, Japan $4.1M AUM 0.16% 1-Year Est. Return

Callan Family Office's WBA Position: Q3 2025 in Review

Callan Family Office sold out of Walgreens Boots Alliance (WBA) in Q3 2025, closing a stake of 19,164 shares — an estimated $220K sold.

Callan Family Office first reported a position in WBA in Q2 2025 and held it in 1 quarter. The position peaked at $220K in Q2 2025. 9 funds tracked by Wall St. Rank hold WBA as of Q3 2025.

Callan Family Office reported no remaining Walgreens Boots Alliance position as of Q3 2025 after selling out during the quarter.
Callan Family Office sold 19,164 Walgreens Boots Alliance shares in Q3 2025, an estimated $220K.
Callan Family Office first reported a position in Walgreens Boots Alliance in Q2 2025 and held it in 1 quarter.
Callan Family Office's Walgreens Boots Alliance position peaked at $220K in Q2 2025.
9 funds tracked by Wall St. Rank held Walgreens Boots Alliance as of Q3 2025.

Based on Callan Family Office's 13F filing for Q3 2025, filed 4 Nov 2025.